a 63162 has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KM; Harris, JE; Jajeh, A; Levin, J; Seed, T | 1 |
| Anderson, KM; Harris, JE; Jajeh, A; Meng, J; Plate, JM; Seed, T | 1 |
2 other study(ies) available for a 63162 and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetamides; Amides; Apoptosis; Base Sequence; Blast Crisis; Blood Cells; Codon; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Microscopy, Electron; Molecular Sequence Data; Oligonucleotides, Antisense; Phenyl Ethers; Pyridines; RNA, Neoplasm; Thymidine; Tritium | 1993 |
Selective inhibitors of 5-lipoxygenase reduce CML blast cell proliferation and induce limited differentiation and apoptosis.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetamides; Amides; Antineoplastic Agents; Apoptosis; Blast Crisis; Cell Differentiation; Cell Division; DNA, Neoplasm; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Phenyl Ethers; Pyridines; Tumor Cells, Cultured | 1995 |